戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  advanced treatment, such as thrombolysis or embolectomy.
2 sociated with lower risks of fetal loss than embolectomy.
3 bolysis, catheter fragmentation, or surgical embolectomy.
4 ts warrant consideration for thrombolysis or embolectomy.
5 oncomitantly in 71 patients for occlusion or embolectomy.
6 e both localized thrombolysis and mechanical embolectomy.
7 41-0.54), angioplasty (0.46, 0.38-0.55), and embolectomy (0.39, 0.35-0.44).
8    Most patients with SMPE were treated with embolectomy (98.9% [91 of 92]), while ECMO was used more
9 liberalized our criteria for acute pulmonary embolectomy and considered operating on patients with an
10 modified Rankin scale did not differ between embolectomy and standard care (3.9 vs. 3.9, P=0.99).
11 niques, strategies, and outcomes of surgical embolectomy and venoarterial extracorporeal membrane oxy
12                                     Surgical embolectomy and/or venoarterial ECMO were compared, betw
13 de systemic fibrinolysis, surgical pulmonary embolectomy, and a growing number of options for cathete
14  on imaging, systemic thrombolysis, surgical embolectomy, and catheter-directed therapy for submassiv
15 atheter-directed therapy, surgical pulmonary embolectomy, and inferior vena cava filter insertion.
16 ous tissue plasminogen activator, mechanical embolectomy appeared to be safe.
17 nts with an algorithm that includes surgical embolectomy as one of several therapeutic options.
18 A was injured using an intravascular balloon embolectomy catheter (2F Fogarty).
19                                  The Fogarty embolectomy catheter and the Arrow-Trerotola device caus
20                     Alternatively, a Fogarty embolectomy catheter can be passed down the single lumen
21 th-arresting lipid via the balloon tip of an embolectomy catheter would limit neointimal hyperplasia
22 s maintained for 40 mins with a 4-Fr Fogarty embolectomy catheter, followed by 2 hrs of reperfusion.
23 tic therapy, inferior vena cava filters, and embolectomy during pregnancy.
24 d escalation of therapy with thrombolysis or embolectomy even if the blood pressure is normal on pres
25 12 women) consecutive patients who underwent embolectomy from October 1999 through October 2001.
26                     Revascularization in the embolectomy group was achieved in 67% of the patients.
27 onsensus treatment recommendations, surgical embolectomy has largely been relegated to patients who h
28 in those with MPE (ECMO in 40.9% [18 of 44], embolectomy in 59.1% [26 of 44]).
29 e of intravenous thrombolysis and mechanical embolectomy in appropriate patients.
30 or arrest, emergent systemic thrombolysis or embolectomy is reasonable, while for low-risk PE, antico
31 s fragmentation, or percutaneous or surgical embolectomy-is best suited to a particular patient.
32 or-circulation strokes to undergo mechanical embolectomy (Merci Retriever or Penumbra System) or rece
33       Our contemporary approach to pulmonary embolectomy no longer confines this operation to a treat
34 ected thrombolysis) and mechanical (surgical embolectomy or catheter-based thrombectomy) reperfusion
35 bolysis) or mechanical reperfusion (surgical embolectomy or catheter-based thrombectomy) with regards
36 idence suggesting surgical therapy (surgical embolectomy or venoarterial extracorporeal membrane oxyg
37 tion and, in select patients, performance of embolectomy rather than pursuing thrombolysis may improv
38 r therapy for acute ischemic stroke, nor was embolectomy shown to be superior to standard care.
39 7% to 1.0% (p = 0.07 for trend) and surgical embolectomy use doubled from 0.3% to 0.6% (p < 0.01 for
40                                              Embolectomy was associated with decreased amputation rat
41                                              Embolectomy was not superior to standard care in patient
42 , pressors, rescue thrombolysis, or surgical embolectomy, were present in 24 patients.